Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Infantile Spasm Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Infantile Spasm Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Infantile Spasm Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GW Pharmaceuticals
Catalyst Pharmaceuticals
Valerion Therapeutics
Retrophin
Anavex Life Sciences
Orphelia Pharma
Mallinckrodt
H Lundbeck
Insys Therapeutics
By Type:
Oral
Parenteral
By End-User:
Hospital
Clinic
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Infantile Spasm Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 China Infantile Spasm Treatment Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.2 China Infantile Spasm Treatment Market Size and Growth Rate of Parenteral from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Infantile Spasm Treatment Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Infantile Spasm Treatment Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 China Infantile Spasm Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Infantile Spasm Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Infantile Spasm Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Oral
-
3.4.2 Market Size and Growth Rate of Parenteral
4 Segmentation of Infantile Spasm Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Infantile Spasm Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Infantile Spasm Treatment in Hospital
-
4.4.2 Market Size and Growth Rate of Infantile Spasm Treatment in Clinic
-
4.4.3 Market Size and Growth Rate of Infantile Spasm Treatment in Other
5 Market Analysis by Regions
-
5.1 China Infantile Spasm Treatment Production Analysis by Regions
-
5.2 China Infantile Spasm Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Infantile Spasm Treatment Landscape Analysis
-
6.1 North China Infantile Spasm Treatment Landscape Analysis by Major Types
-
6.2 North China Infantile Spasm Treatment Landscape Analysis by Major End-Users
7 Central China Infantile Spasm Treatment Landscape Analysis
-
7.1 Central China Infantile Spasm Treatment Landscape Analysis by Major Types
-
7.2 Central China Infantile Spasm Treatment Landscape Analysis by Major End-Users
8 South China Infantile Spasm Treatment Landscape Analysis
-
8.1 South China Infantile Spasm Treatment Landscape Analysis by Major Types
-
8.2 South China Infantile Spasm Treatment Landscape Analysis by Major End-Users
9 East China Infantile Spasm Treatment Landscape Analysis
-
9.1 East China Infantile Spasm Treatment Landscape Analysis by Major Types
-
9.2 East China Infantile Spasm Treatment Landscape Analysis by Major End-Users
10 Northeast China Infantile Spasm Treatment Landscape Analysis
-
10.1 Northeast China Infantile Spasm Treatment Landscape Analysis by Major Types
-
10.2 Northeast China Infantile Spasm Treatment Landscape Analysis by Major End-Users
11 Southwest China Infantile Spasm Treatment Landscape Analysis
-
11.1 Southwest China Infantile Spasm Treatment Landscape Analysis by Major Types
-
11.2 Southwest China Infantile Spasm Treatment Landscape Analysis by Major End-Users
12 Northwest China Infantile Spasm Treatment Landscape Analysis
-
12.1 Northwest China Infantile Spasm Treatment Landscape Analysis by Major Types
-
12.2 Northwest China Infantile Spasm Treatment Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 GW Pharmaceuticals
-
13.1.1 GW Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Catalyst Pharmaceuticals
-
13.2.1 Catalyst Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Valerion Therapeutics
-
13.3.1 Valerion Therapeutics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Retrophin
-
13.4.1 Retrophin Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Anavex Life Sciences
-
13.5.1 Anavex Life Sciences Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Orphelia Pharma
-
13.6.1 Orphelia Pharma Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Mallinckrodt
-
13.7.1 Mallinckrodt Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 H Lundbeck
-
13.8.1 H Lundbeck Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Insys Therapeutics
-
13.9.1 Insys Therapeutics Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Infantile Spasm Treatment Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Infantile Spasm Treatment Market Size and Growth Rate of Parenteral from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Infantile Spasm Treatment Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Infantile Spasm Treatment Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure China Infantile Spasm Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Infantile Spasm Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Infantile Spasm Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Infantile Spasm Treatment
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Infantile Spasm Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Infantile Spasm Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Parenteral
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Infantile Spasm Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Infantile Spasm Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Other
-
Table China Infantile Spasm Treatment Production by Regions
-
Table China Infantile Spasm Treatment Production Share by Regions
-
Figure China Infantile Spasm Treatment Production Share by Regions in 2016
-
Figure China Infantile Spasm Treatment Production Share by Regions in 2021
-
Figure China Infantile Spasm Treatment Production Share by Regions in 2027
-
Table China Infantile Spasm Treatment Consumption by Regions
-
Table China Infantile Spasm Treatment Consumption Share by Regions
-
Figure China Infantile Spasm Treatment Consumption Share by Regions in 2016
-
Figure China Infantile Spasm Treatment Consumption Share by Regions in 2021
-
Figure China Infantile Spasm Treatment Consumption Share by Regions in 2027
-
Table North China Infantile Spasm Treatment Consumption by Types from 2016 to 2027
-
Table North China Infantile Spasm Treatment Consumption Share by Types from 2016 to 2027
-
Figure North China Infantile Spasm Treatment Consumption Share by Types in 2016
-
Figure North China Infantile Spasm Treatment Consumption Share by Types in 2021
-
Figure North China Infantile Spasm Treatment Consumption Share by Types in 2027
-
Table North China Infantile Spasm Treatment Consumption by End-Users from 2016 to 2027
-
Table North China Infantile Spasm Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure North China Infantile Spasm Treatment Consumption Share by End-Users in 2016
-
Figure North China Infantile Spasm Treatment Consumption Share by End-Users in 2021
-
Figure North China Infantile Spasm Treatment Consumption Share by End-Users in 2027
-
Table Central China Infantile Spasm Treatment Consumption by Types from 2016 to 2027
-
Table Central China Infantile Spasm Treatment Consumption Share by Types from 2016 to 2027
-
Figure Central China Infantile Spasm Treatment Consumption Share by Types in 2016
-
Figure Central China Infantile Spasm Treatment Consumption Share by Types in 2021
-
Figure Central China Infantile Spasm Treatment Consumption Share by Types in 2027
-
Table Central China Infantile Spasm Treatment Consumption by End-Users from 2016 to 2027
-
Table Central China Infantile Spasm Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Infantile Spasm Treatment Consumption Share by End-Users in 2016
-
Figure Central China Infantile Spasm Treatment Consumption Share by End-Users in 2021
-
Figure Central China Infantile Spasm Treatment Consumption Share by End-Users in 2027
-
Table South China Infantile Spasm Treatment Consumption by Types from 2016 to 2027
-
Table South China Infantile Spasm Treatment Consumption Share by Types from 2016 to 2027
-
Figure South China Infantile Spasm Treatment Consumption Share by Types in 2016
-
Figure South China Infantile Spasm Treatment Consumption Share by Types in 2021
-
Figure South China Infantile Spasm Treatment Consumption Share by Types in 2027
-
Table South China Infantile Spasm Treatment Consumption by End-Users from 2016 to 2027
-
Table South China Infantile Spasm Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South China Infantile Spasm Treatment Consumption Share by End-Users in 2016
-
Figure South China Infantile Spasm Treatment Consumption Share by End-Users in 2021
-
Figure South China Infantile Spasm Treatment Consumption Share by End-Users in 2027
-
Table East China Infantile Spasm Treatment Consumption by Types from 2016 to 2027
-
Table East China Infantile Spasm Treatment Consumption Share by Types from 2016 to 2027
-
Figure East China Infantile Spasm Treatment Consumption Share by Types in 2016
-
Figure East China Infantile Spasm Treatment Consumption Share by Types in 2021
-
Figure East China Infantile Spasm Treatment Consumption Share by Types in 2027
-
Table East China Infantile Spasm Treatment Consumption by End-Users from 2016 to 2027
-
Table East China Infantile Spasm Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure East China Infantile Spasm Treatment Consumption Share by End-Users in 2016
-
Figure East China Infantile Spasm Treatment Consumption Share by End-Users in 2021
-
Figure East China Infantile Spasm Treatment Consumption Share by End-Users in 2027
-
Table Northeast China Infantile Spasm Treatment Consumption by Types from 2016 to 2027
-
Table Northeast China Infantile Spasm Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Infantile Spasm Treatment Consumption Share by Types in 2016
-
Figure Northeast China Infantile Spasm Treatment Consumption Share by Types in 2021
-
Figure Northeast China Infantile Spasm Treatment Consumption Share by Types in 2027
-
Table Northeast China Infantile Spasm Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast China Infantile Spasm Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Infantile Spasm Treatment Consumption Share by End-Users in 2016
-
Figure Northeast China Infantile Spasm Treatment Consumption Share by End-Users in 2021
-
Figure Northeast China Infantile Spasm Treatment Consumption Share by End-Users in 2027
-
Table Southwest China Infantile Spasm Treatment Consumption by Types from 2016 to 2027
-
Table Southwest China Infantile Spasm Treatment Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Infantile Spasm Treatment Consumption Share by Types in 2016
-
Figure Southwest China Infantile Spasm Treatment Consumption Share by Types in 2021
-
Figure Southwest China Infantile Spasm Treatment Consumption Share by Types in 2027
-
Table Southwest China Infantile Spasm Treatment Consumption by End-Users from 2016 to 2027
-
Table Southwest China Infantile Spasm Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Infantile Spasm Treatment Consumption Share by End-Users in 2016
-
Figure Southwest China Infantile Spasm Treatment Consumption Share by End-Users in 2021
-
Figure Southwest China Infantile Spasm Treatment Consumption Share by End-Users in 2027
-
Table Northwest China Infantile Spasm Treatment Consumption by Types from 2016 to 2027
-
Table Northwest China Infantile Spasm Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Infantile Spasm Treatment Consumption Share by Types in 2016
-
Figure Northwest China Infantile Spasm Treatment Consumption Share by Types in 2021
-
Figure Northwest China Infantile Spasm Treatment Consumption Share by Types in 2027
-
Table Northwest China Infantile Spasm Treatment Consumption by End-Users from 2016 to 2027
-
Table Northwest China Infantile Spasm Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Infantile Spasm Treatment Consumption Share by End-Users in 2016
-
Figure Northwest China Infantile Spasm Treatment Consumption Share by End-Users in 2021
-
Figure Northwest China Infantile Spasm Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GW Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GW Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of GW Pharmaceuticals
-
Figure Revenue and Market Share Analysis of GW Pharmaceuticals
-
Table Product and Service Introduction of GW Pharmaceuticals
-
Table Company Profile and Development Status of Catalyst Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalyst Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Catalyst Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Catalyst Pharmaceuticals
-
Table Product and Service Introduction of Catalyst Pharmaceuticals
-
Table Company Profile and Development Status of Valerion Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valerion Therapeutics
-
Figure Sales and Growth Rate Analysis of Valerion Therapeutics
-
Figure Revenue and Market Share Analysis of Valerion Therapeutics
-
Table Product and Service Introduction of Valerion Therapeutics
-
Table Company Profile and Development Status of Retrophin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Retrophin
-
Figure Sales and Growth Rate Analysis of Retrophin
-
Figure Revenue and Market Share Analysis of Retrophin
-
Table Product and Service Introduction of Retrophin
-
Table Company Profile and Development Status of Anavex Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anavex Life Sciences
-
Figure Sales and Growth Rate Analysis of Anavex Life Sciences
-
Figure Revenue and Market Share Analysis of Anavex Life Sciences
-
Table Product and Service Introduction of Anavex Life Sciences
-
Table Company Profile and Development Status of Orphelia Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orphelia Pharma
-
Figure Sales and Growth Rate Analysis of Orphelia Pharma
-
Figure Revenue and Market Share Analysis of Orphelia Pharma
-
Table Product and Service Introduction of Orphelia Pharma
-
Table Company Profile and Development Status of Mallinckrodt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt
-
Figure Sales and Growth Rate Analysis of Mallinckrodt
-
Figure Revenue and Market Share Analysis of Mallinckrodt
-
Table Product and Service Introduction of Mallinckrodt
-
Table Company Profile and Development Status of H Lundbeck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of H Lundbeck
-
Figure Sales and Growth Rate Analysis of H Lundbeck
-
Figure Revenue and Market Share Analysis of H Lundbeck
-
Table Product and Service Introduction of H Lundbeck
-
Table Company Profile and Development Status of Insys Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Insys Therapeutics
-
Figure Sales and Growth Rate Analysis of Insys Therapeutics
-
Figure Revenue and Market Share Analysis of Insys Therapeutics
-
Table Product and Service Introduction of Insys Therapeutics
-
